Valuation: Medico Intercontinental Limited

Market Cap 255M 2.67M 2.32M 2.15M 1.99M 3.74M 3.81M 25.51M 9.99M 127M 10.03M 9.81M 426M P/E 2024
10.1x
P/E 2025 7.01x
Enterprise Value 397M 4.16M 3.62M 3.36M 3.1M 5.83M 5.94M 39.74M 15.56M 197M 15.63M 15.29M 664M EV / Sales 2024
0.58x
EV / Sales 2025 0.52x
Free-Float
38.75%
Yield 2024 *
-
Yield 2025 -
05-22 Medico Intercontinental Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-14 Medico Intercontinental Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
25-08-14 Medico Intercontinental Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-07-14 Medico Intercontinental Limited Approves the Appointment of Puneeta Sharma as Company Secretary and Compliance Officer, Effective from 14 July, 2025 CI
25-05-30 Medico Intercontinental Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025 CI
25-04-22 Medico Intercontinental Limited Announces Resignation of Puneeta Sharma as Company Secretary & Compliance Officer, Effective 22 April, 2025 CI
24-11-14 Medico Intercontinental Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
24-08-13 Medico Intercontinental Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
24-05-25 Medico Intercontinental Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
24-05-25 Medico Intercontinental Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
24-04-25 Medico Intercontinental Limited Announces Resignation of Nikul Dipakbhai Shah as Independent Director CI
24-04-09 Medico Intercontinental Limited Proposes to Incorporate Joint Venture Partnership Firm CI
24-02-14 Medico Intercontinental Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
1 day+2.80%
1 week+2.42%
Current month-15.82%
1 month-15.82%
3 months+3.99%
6 months-32.80%
Current year-37.50%
1 week 23.5
Extreme 23.5
27.99
1 month 23.5
Extreme 23.5
33.25
Current year 20.61
Extreme 20.61
42.9
1 year 20.61
Extreme 20.61
43
3 years 20.61
Extreme 20.61
122
5 years 20.61
Extreme 20.61
122
10 years 8
Extreme 8
132.1
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2019-08-11
Compliance Officer - 2019-05-31
Director TitleAgeSince
Chairman - 2019-04-07
Director/Board Member 53 2019-03-22
Director/Board Member - 2022-11-13
Change 5-day change 1-year change 3-year change Capi.($)
+2.80%+2.42%-33.26%-65.51% 2.55M
-0.53%+1.87%+14.81%+74.09% 50.29B
-1.81%-0.49%+51.99%+112.44% 37.24B
+0.46%+5.76%-5.53%+25.38% 12.41B
+1.05%+1.17%+13.23%+78.22% 11.65B
-1.14%+0.96%+31.25%+132.30% 9.17B
-2.99%-2.09%+41.02%-8.36% 7.24B
+1.45%+2.23%+15.52%+34.12% 6.8B
+1.99%+1.31%+3.73%+183.54% 6.47B
+0.21%-5.18%-34.40%-1.46% 5.46B
Average +0.15%+2.37%+9.84%+56.48% 14.67B
Weighted average by Cap. -0.57%+2.83%+22.43%+79.76%

Financials

2024 2025
Net sales 715M 7.49M 6.51M 6.04M 5.57M 10.5M 10.69M 71.52M 28M 355M 28.13M 27.51M 1.19B 963M 10.08M 8.76M 8.13M 7.5M 14.13M 14.39M 96.3M 37.71M 478M 37.87M 37.04M 1.61B
Net income 39.47M 413K 359K 333K 308K 579K 590K 3.95M 1.55M 19.6M 1.55M 1.52M 65.92M 50.57M 530K 460K 427K 394K 742K 756K 5.06M 1.98M 25.12M 1.99M 1.95M 84.47M
Net Debt 14.89M 156K 135K 126K 116K 219K 223K 1.49M 583K 7.4M 586K 573K 24.87M 142M 1.49M 1.3M 1.2M 1.11M 2.09M 2.13M 14.24M 5.57M 70.69M 5.6M 5.48M 238M
Logo Medico Intercontinental Limited
Medico Intercontinental Ltd is engaged in the business of trading pharmaceutical products. It provides a platform for all research-based biopharmaceutical companies. Its product categories include Gastro, Uro, Nutrition, Cosmetology, Health devices, Hospital, and other areas. Its products include ACIFACT-BLI, ACIFACT-P, ACIFACT-SP (ALU-ALU), ALBECTIN, ALFACARE-D3, ARSUFACT Combokit, BALOFACT, CYCLOFACT 400, UDIFACT 150, XOFACT-4, ZIFT SL-250, ZYMIX, ARGIFACT, CLIANCIACT POWDER, RELIEVE CZ, VOLIREX SPRAY, RACIMAX SACHET, PERMACT, OROFACT, KTZ, FEMYACT, LIVOFACT, ZYMIX SY, ULTRATONE SY, ALBECTIN SUS, BECOFACT DROPS, MEFACT P SUS, ONCARE SOLUTION, OFCARE-FORTE SUS, PRODOM CV SY, RELIBEN SUSP, ZIFT SUSP-200, MGCIPACT EYE DROP, OROFACT-PASTE (lamy), OROFACT MOUTH ULCER GEL, CAMBOGIA, LUBRIACT, HIZEN, and CALAMED LOTION. Its subsidiaries include Evagrace Pharma Private Limited, Ritz Formulations Private Limited, Sungrace Pharma Private Limited, and Azillian Healthcare Private Limited.
Employees
38
Date Price Change Volume
26-07-31 25.00 +2.80% 1,635
26-07-30 ₹24.32 -1.74% 1,643
26-07-29 ₹24.75 -3.92% 439
26-07-28 ₹25.76 -3.45% 900
26-07-27 ₹26.68 +2.46% 178
  1. Stock Market
  2. Stocks
  3. ICLF Stock